Electrosteel Castings (500128) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
25 Oct, 2026Executive summary
Q1 FY25 consolidated total income rose 18.9% YoY to INR 2,036.01 crore; EBITDA increased 101.6% to INR 378 crore and PAT rose 201.7% to INR 226.04 crore.
Strong domestic demand, scale benefits and operating efficiencies supported growth and margin expansion.
Financial highlights
Consolidated revenue was INR 2,011.90 crore versus INR 1,685.04 crore in Q1 FY24; gross profit rose 30.6% to INR 1,020 crore, with gross margin up 446 bps to 50.1%.
Consolidated EBITDA margin expanded 761 bps to 18.5%; EBIT rose 120.2% to INR 346 crore, while finance cost declined 27.5% to INR 41 crore.
Standalone total income increased 21% to INR 1,851 crore; EBITDA rose 91.9% to INR 354 crore and PAT increased 160.9% to INR 212 crore.
Standalone EBITDA margin reached 19.1%, up 705 bps; PAT margin was 11.5%, up 615 bps YoY.
Outlook and guidance
FY25 DI pipe sales volume is expected at ~8.5 lakh tonnes; management expects to sell most of the additional capacity coming on stream.
Capacity expansion targets 10 lakh tonnes per annum by FY26; ongoing facilities are expected to commission by end-Q3, with some benefit from Q4.
Management expects export contribution to return toward 20%; Q1 exports were reduced by design amid stronger domestic demand and volatile freight costs.
Management said current EBITDA-per-tonne tailwinds could persist and endorsed ~INR 15,000 per tonne as maintainable, without giving a full-year figure; fittings contribution target is 5%–10% versus 4%–5% currently.
Latest events from Electrosteel Castings
- H1 growth and FY26 expansion plans contrasted with weaker Q2 and qualified review.500128
Q2 24/25 - Shutdown-hit Q3 contrasted with nine-month growth and capacity expansion amid unresolved audit matters.500128
Q3 24/25 - Shutdown-hit FY25 earnings, capacity expansion and unresolved audit matters define the outlook.500128
Q4 24/25 - Funding slowdown cut Q1 earnings; H2 recovery and T.I.S. valve expansion shape the outlook.500128
Q1 25/26 - Weak JJM funding cut Q2 earnings; demand and volumes are expected to recover.500128
Q2 25/26 - JJM delays weakened Q3 earnings; exports and funding resumption underpin recovery hopes.500128
Q3 25/26 - FY26 earnings fell on weak domestic demand; gradual recovery faces cost and audit risks.500128
Q4 25/26 - Lower Q1 earnings amid delayed water projects and unresolved legal exposures.500128
Q1 26/27